Regeneron Pharmaceuticals (REGN) News Today $547.75 +9.64 (+1.79%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$549.15 +1.40 (+0.26%) As of 07/8/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Leerink Partnrs Has Negative Estimate for REGN Q3 Earnings2 hours ago | americanbankingnews.comREGN - Regeneron Pharmaceuticals Inc Key Metrics - MorningstarJuly 8 at 2:40 PM | morningstar.comM1 Cash-Heavy Stock to Own for Decades and 2 to IgnoreJuly 8 at 2:40 PM | finance.yahoo.comRegeneron Advances Immunotherapy Combinations for NSCLC: A Study UpdateJuly 8 at 12:37 PM | tipranks.comDekaBank Deutsche Girozentrale Increases Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 8 at 10:15 AM | marketbeat.comRegeneron’s Lynozyfic Gains Accelerated FDA Approval for Multiple MyelomaJuly 8 at 9:39 AM | msn.comLeerink Partnrs Issues Negative Outlook for REGN EarningsJuly 8 at 7:30 AM | marketbeat.comChina Universal Asset Management Co. Ltd. Has $16.26 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 7 at 8:50 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Trimmed by Impax Asset Management Group plcJuly 7 at 5:16 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 7 at 2:46 AM | marketbeat.comBank of New York Mellon Corp Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 6 at 6:49 AM | marketbeat.comRegeneron Pharmaceuticals (REGN) Announces Approval of Dupixent in the USJuly 6 at 5:41 AM | msn.comCalamos Advisors LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 6 at 5:34 AM | marketbeat.comAugust 22nd Options Now Available For Regeneron Pharmaceuticals, Inc. (REGN) - NasdaqJuly 5, 2025 | nasdaq.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Braun Stacey Associates Inc.July 5, 2025 | marketbeat.com2 Beaten-Down Stocks to Buy and HoldJuly 5, 2025 | fool.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by IFM Investors Pty LtdJuly 5, 2025 | marketbeat.comPrincipal Financial Group Inc. Has $82.21 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 5, 2025 | marketbeat.comTeacher Retirement System of Texas Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 5, 2025 | marketbeat.comREGN - Regeneron Pharmaceuticals Inc Valuation - MorningstarJuly 4, 2025 | morningstar.comMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by GF Fund Management CO. LTD.July 4, 2025 | marketbeat.comVontobel Holding Ltd. Has $4.66 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 4, 2025 | marketbeat.comRegeneron’s Pozelimab Study: A New Hope for Rare Disease PatientsJuly 3, 2025 | tipranks.comFirst Horizon Advisors Inc. Grows Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 3, 2025 | marketbeat.comRegeneron Pharmaceuticals (REGN) and Sanofi Announce Approval of Dupixent® By US FDAJuly 3, 2025 | msn.comRegeneron stock rises after FDA approval for blood cancer therapyJuly 2, 2025 | investing.comRegeneron Shares Climb Following FDA Approval of Blood Cancer TreatmentJuly 2, 2025 | msn.comRegeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock JumpsJuly 2, 2025 | msn.comRegeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer TreatmentJuly 2, 2025 | wsj.comUS FDA approves Regeneron's blood cancer therapyJuly 2, 2025 | reuters.comRegeneron Pharmaceuticals Receives FDA Accelerated Approval for Lynozyfic™ in Treating Relapsed or Refractory Multiple MyelomaJuly 2, 2025 | quiverquant.comQRegeneron Pharmaceuticals Unusual Options Activity For July 01July 2, 2025 | benzinga.comHeart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong TailwindJuly 2, 2025 | msn.comSumitomo Mitsui DS Asset Management Company Ltd Sells 2,531 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 2, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Lowers Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 2, 2025 | marketbeat.comRegeneron and Bayer’s Promising Phase 3 Study on Aflibercept for Diabetic Macular EdemaJuly 1, 2025 | tipranks.comRegeneron and Bayer’s High-Dose Aflibercept Study: Key Insights for InvestorsJuly 1, 2025 | tipranks.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by New York State Teachers Retirement SystemJuly 1, 2025 | marketbeat.comBessemer Group Inc. Has $772,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 1, 2025 | marketbeat.comArgus Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to HoldJuly 1, 2025 | americanbankingnews.comRegeneron Pharmaceuticals (NasdaqGS:REGN) Exits Multiple Russell Growth IndicesJune 30, 2025 | finance.yahoo.comRegeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by ArgusJune 30, 2025 | marketbeat.comRedJay Asset Management Inc. Invests $1.27 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 30, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by KBC Group NVJune 29, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Sumitomo Mitsui Trust Group Inc.June 29, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by Mirae Asset Global Investments Co. Ltd.June 29, 2025 | marketbeat.comREGN - Regeneron Pharmaceuticals Inc News - MorningstarJune 28, 2025 | morningstar.comMDiversified Trust Co Acquires 544 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 28, 2025 | marketbeat.comOppenheimer Asset Management Inc. Takes $1.25 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)June 28, 2025 | marketbeat.comRegeneron’s Phase 3 Trial: A New Hope for Follicular Lymphoma TreatmentJune 27, 2025 | tipranks.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.950.57▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼3732▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Moderna News Intellia Therapeutics News Vir Biotechnology News Vertex Pharmaceuticals News AbbVie News Eli Lilly and Company News Merck & Co., Inc. News Pfizer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
